Case File: Wilhite, on behalf of Expensify IPO investors (Creditor) vs. Expensify, Inc. (Debtor)
Case No.: 3:23-cv-01784-JR
Court: U.S. District Court, District of Oregon
Settlement Amount: $9,500,000, deposited into escrow
Final Approval: June 30, 2026
Who Bought In: Investors who acquired Expensify stock in, or traceable to, the November 2021 IPO
Who Funded It: $6.9 million from insurance and $2.6 million from Expensify
Status: Settled. The claims were allegations, and the court has not ruled on who was right.
When a company goes public, its registration statement is the promise it makes to the market. Investors read it, price the shares off it, and trust that it tells the full story. A group of Expensify shareholders said that promise fell short, and that they paid for it when the stock slid. Nearly three years after the lawsuit was filed, the dispute ended in a $9.5 million settlement that a federal court approved on June 30, 2026.
The money is only part of the story. How the deal was funded, how long it took, and the lawsuits still sitting behind it show how a securities case moves from complaint to check.
Who Is Expensify?
Expensify, Inc. is a Delaware corporation formed in 2009 that sells expense management software. Its platform connects with accounting tools such as QuickBooks, Xero and NetSuite, and the company also issues a charge card, the Expensify Card, mainly to U.S. business customers. Its stock trades on Nasdaq under the ticker EXFY.
The company went public on November 11, 2021, selling 9.73 million shares at $27.00 each, according to the complaint and to Stanford’s securities class action case summary. That price matters for the rest of this story. The 10-Q Expensify filed for the period ended June 30, 2026 values its shares at $1.57 for option-pricing purposes.
What the Investors Claimed
The lawsuit was filed on November 29, 2023, as Wilhite v. Expensify, Inc., et al. It named the company, its executive officers and several current and former directors. David Barrett was the company’s chief executive at the time of the IPO, according to the complaint.
The legal claims came under Sections 11 and 15 of the Securities Act of 1933. In general terms, Section 11 targets false or misleading statements in a registration statement, and Section 15 reaches the people who control the company. The case rested on the offering documents themselves, not on later statements to the market.
Bloomberg Law describes the allegations as misleading investors about the company’s bottom-up business model and about the effects of price hikes. A plaintiff-side law firm announcement points to the stretch that followed. On August 8, 2023, Expensify reported second-quarter results that missed analyst expectations and withdrew its revenue growth guidance. The firm says the shares fell more than 28% the next day.
Those are the plaintiffs’ allegations. The settlement does not decide whether they are true.
How the Case Played Out
The path from filing to final approval was long, and the 10-Q lays it out step by step:
- November 29, 2023: The class action is filed in the District of Oregon.
- January 29, 2024: Three shareholders ask to be appointed lead plaintiff.
- December 17, 2025: After mediation during the discovery phase, the parties agree in principle to settle for $9.5 million.
- February 12, 2026: The plaintiff files the settlement agreement and asks for preliminary approval.
- February 23, 2026: The court grants preliminary approval.
- April 28, 2026: The plaintiff asks for final approval and for attorneys’ fees.
- June 30, 2026: The court grants final approval at a hearing.
That is a little over 30 months from complaint to settlement in principle, and the deal arrived while the case was still in discovery, before any trial.
Who Actually Pays?
The headline number is $9.5 million, but Expensify did not write that whole check. During the first half of 2026, the company deposited $9.5 million into escrow, and its filing breaks the amount into two pieces:
- $6.9 million was recovered under the company’s insurance policies
- $2.6 million was paid by Expensify itself
That puts insurance at roughly 73% of the fund. The 10-K for 2025 shows the same pattern from the accounting side. Expensify booked a $2.8 million net expense for the settlement in 2025, after counting an expected insurance recovery.
For anyone covering corporate legal costs, this is a useful reminder. In securities class actions, the sticker price and the cost to the company can be far apart because of directors-and-officers coverage.
The Part Investors Care About: Fees and Payouts
Bloomberg Law reports that the court certified a class of investors who bought Expensify stock in or traceable to the IPO registration statement, and awarded class counsel fees of 25% of the settlement total. On a $9.5 million fund, that works out to about $2.4 million, which is our own arithmetic and not a figure from the court order.
Money left after fees and administration goes to class members on a pro rata basis, according to the settlement page of plaintiff-side firm Kessler Topaz Meltzer & Check. Each person’s share depends on four things:
- How many valid claims were filed
- How many shares were bought and sold
- When the purchases and sales happened
- What was paid and what was received
The deadline to submit a claim was June 29, 2026, one day before the final hearing. The claims administrator was Strategic Claims Services, and the settlement website was expensifysecuritiessettlement.com. We could not find a published per-share payout figure.
The Lawsuits That Are Still Open
Settling the class action did not end Expensify’s litigation. The 10-Q lists four shareholder derivative lawsuits, all in the District of Oregon, which name the company as a nominal defendant and its officers and directors as defendants:
- O’Halloran v. Barrett: filed May 9, 2024, and stayed on August 14, 2024 while motions to dismiss in the class action were resolved
- Da Silva v. Barrett: filed December 18, 2024
- Choi v. Barrett: filed July 23, 2025, and stayed on October 20, 2025 until the class action reached a final resolution
- Mangiagli v. Barrett: filed March 20, 2026
The defendants deny wrongdoing and say they will keep defending. Expensify says it cannot estimate the probability or the amount of any liability, and it expects any future settlement in these cases to be covered entirely by its insurance policies.
Where Expensify Stands Now
The settlement landed in a year when the company was working through other pressures. In April 2026, Nasdaq sent a deficiency letter because the stock had closed below $1.00 for 30 straight business days. On May 28, 2026, Nasdaq said the company had regained compliance.
For the three months ended June 30, 2026, the 10-Q reports revenue of $33.9 million, down from $35.8 million a year earlier, and a net loss of $3.9 million, compared with $8.8 million in the same quarter of 2025. The company held $65.8 million in cash and cash equivalents at quarter-end. The $9.5 million litigation reserve that sat on its balance sheet at the end of 2025 was gone by June 30, 2026.
The Takeaway
The Expensify settlement is a clean example of how an IPO-era dispute resolves. Investors alleged the offering documents painted too rosy a picture, the company settled during discovery, and insurance covered most of the bill. The court approved it, lawyers took their fee, and class members who filed on time will split what remains.
It is not fully closed. The derivative suits are still pending, and nothing in the settlement says whether the original allegations were right. What it leaves behind is a $9.5 million fund, a stock now trading far below its $27 debut price, and a paper trail of filings for anyone who wants to follow the money.
SOURCE:
This article is based on the official Justice Department press release issued by the Office of Public Affairs on September 17, 2026, which was used to confirm the settlement amount, the allegation period, the case caption and number, the names of the whistleblowers, the payment structure, and the statements of Assistant Attorney General Brett A. Shumate, U.S. Attorney Dominick S. Gerace II and HHS-OIG’s Miranda L. Bennett. It is cross-referenced against coverage from McKnight’s Senior Living, which supplied the December 2020 filing date, the first installment amount, the separate retaliation claims, and the 2010 settlement, and against reporting from the Washington Times and a Maryland-focused enforcement roundup. The claims resolved by the settlement are allegations only, and there has been no determination of liability.